NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Eli Lilly and Company
University Hospital, Lille
Revolution Medicines, Inc.
Eli Lilly and Company
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
Revolution Medicines, Inc.
Stanford University
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Revolution Medicines, Inc.
Syndax Pharmaceuticals
Syndax Pharmaceuticals
University Hospital, Lille
Cliniques universitaires Saint-Luc- Université Catholique de Louvain